C P Reinert1, B Federmann2, J Hofmann3, H Bösmüller2, S Wirths4, J Fritz5, M Horger3. 1. Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Hoppe-Seyler-Str.3, 72076, Tübingen, Germany. christian.reinert@med.uni-tuebingen.de. 2. Department of Pathology and Neuropathology, University Hospital Tübingen, Liebermeisterstraße 8, 72076, Tübingen, Germany. 3. Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Hoppe-Seyler-Str.3, 72076, Tübingen, Germany. 4. Department of Hematology and Oncology, University Hospital Tübingen, Otfried-Müller-Str. 10, 72076, Tübingen, Germany. 5. Russell H. Morgan Department of Radiology and Radiological, Johns Hopkins University School of Medicine, Science, 601 N. Caroline Street, JHOC 3142, Baltimore, MD, 21287, USA.
Abstract
OBJECTIVE: To test the hypothesis that both indolent and aggressive chronic lymphocytic leukemia (CLL) can be differentiated from diffuse large B cell lymphoma (DLBCL) of Richter syndrome (RS) by CT texture analysis (CTTA) of involved lymph nodes. MATERIAL AND METHODS: We retrospectively included 52 patients with indolent CLL (26/52), aggressive CLL (8/52), and DLBCL of RS (18/52), who underwent standardized contrast-enhanced CT. In main lymphoma tissue, VOIs were generated from which CTTA features including first-, second-, and higher-order textural features were extracted. CTTA features were compared between the entire CLL group, the indolent CLL subtype, the aggressive CLL subtype, and DLBCL using a Kruskal-Wallis test. All p values were adjusted after the Bonferroni correction. ROC analyses for significant CTTA features were performed to determine cut-off values for differentiation between the groups. RESULTS: Compared with DLBCL of RS, CTTA of the entire CLL group showed significant differences of entropy heterogeneity (p < 0.001), mean intensity (p < 0.001), mean average (p = 0.02), and number non-uniformity gray-level dependence matrix (NGLDM) (p = 0.03). Indolent CLL significantly differed for entropy (p < 0.001), uniformity of heterogeneity (p = 0.02), mean intensity (p < 0.001), and mean average (p = 0.01). Aggressive CLL showed significant differences in mean intensity (p = 0.04). For differentiation between CLL and DLBCL of RS, cut-off values for mean intensity and entropy of heterogeneity were defined (e.g., 6.63 for entropy heterogeneity [aggressive CLL vs. DLBCL]; sensitivity 0.78; specificity 0.63). CONCLUSIONS: CTTA features of ultrastructure and vascularization significantly differ in CLL compared with that in DLBCL of Richter syndrome, allowing complementary to visual features for noninvasive differentiation by contrast-enhanced CT. KEY POINTS: • Richter transformation of CLL into DLBCL results in structural changes in lymph node architecture and vascularization that can be detected by CTTA. • First-order CT textural features including intensity and heterogeneity significantly differ between both indolent CLL and aggressive CLL and DLBCL of Richter syndrome. • CT texture analysis allows for noninvasive detection of Richter syndrome which is of prognostic value.
OBJECTIVE: To test the hypothesis that both indolent and aggressive chronic lymphocytic leukemia (CLL) can be differentiated from diffuse large B cell lymphoma (DLBCL) of Richter syndrome (RS) by CT texture analysis (CTTA) of involved lymph nodes. MATERIAL AND METHODS: We retrospectively included 52 patients with indolent CLL (26/52), aggressive CLL (8/52), and DLBCL of RS (18/52), who underwent standardized contrast-enhanced CT. In main lymphoma tissue, VOIs were generated from which CTTA features including first-, second-, and higher-order textural features were extracted. CTTA features were compared between the entire CLL group, the indolent CLL subtype, the aggressive CLL subtype, and DLBCL using a Kruskal-Wallis test. All p values were adjusted after the Bonferroni correction. ROC analyses for significant CTTA features were performed to determine cut-off values for differentiation between the groups. RESULTS: Compared with DLBCL of RS, CTTA of the entire CLL group showed significant differences of entropy heterogeneity (p < 0.001), mean intensity (p < 0.001), mean average (p = 0.02), and number non-uniformity gray-level dependence matrix (NGLDM) (p = 0.03). Indolent CLL significantly differed for entropy (p < 0.001), uniformity of heterogeneity (p = 0.02), mean intensity (p < 0.001), and mean average (p = 0.01). Aggressive CLL showed significant differences in mean intensity (p = 0.04). For differentiation between CLL and DLBCL of RS, cut-off values for mean intensity and entropy of heterogeneity were defined (e.g., 6.63 for entropy heterogeneity [aggressive CLL vs. DLBCL]; sensitivity 0.78; specificity 0.63). CONCLUSIONS:CTTA features of ultrastructure and vascularization significantly differ in CLL compared with that in DLBCL of Richter syndrome, allowing complementary to visual features for noninvasive differentiation by contrast-enhanced CT. KEY POINTS: • Richter transformation of CLL into DLBCL results in structural changes in lymph node architecture and vascularization that can be detected by CTTA. • First-order CT textural features including intensity and heterogeneity significantly differ between both indolent CLL and aggressive CLL and DLBCL of Richter syndrome. • CT texture analysis allows for noninvasive detection of Richter syndrome which is of prognostic value.
Entities:
Keywords:
Leukemia, lymphocytic, chronic, B cell; Lymphoma, large B cell, diffuse; Texture analysis; Tomography, X-ray-computed
Authors: Davide Rossi; Valeria Spina; Clara Deambrogi; Silvia Rasi; Luca Laurenti; Kostas Stamatopoulos; Luca Arcaini; Marco Lucioni; Gabrielle B Rocque; Zijun Y Xu-Monette; Carlo Visco; Julie Chang; Ekaterina Chigrinova; Francesco Forconi; Roberto Marasca; Caroline Besson; Theodora Papadaki; Marco Paulli; Luigi M Larocca; Stefano A Pileri; Valter Gattei; Francesco Bertoni; Robin Foà; Ken H Young; Gianluca Gaidano Journal: Blood Date: 2011-01-25 Impact factor: 22.113
Authors: John F Bruzzi; Homer Macapinlac; Apostolia M Tsimberidou; Mylene T Truong; Michael J Keating; Edith M Marom; Reginald F Munden Journal: J Nucl Med Date: 2006-08 Impact factor: 10.057
Authors: Scott J Lee; Ryan Zea; David H Kim; Meghan G Lubner; Dustin A Deming; Perry J Pickhardt Journal: Eur Radiol Date: 2017-11-21 Impact factor: 5.315
Authors: Johanna S Enke; Jan H Moltz; Melvin D'Anastasi; Wolfgang G Kunz; Christian Schmidt; Stefan Maurus; Alexander Mühlberg; Alexander Katzmann; Michael Sühling; Horst Hahn; Dominik Nörenberg; Thomas Huber Journal: Cancers (Basel) Date: 2022-01-29 Impact factor: 6.639
Authors: Catharina Silvia Lisson; Christoph Gerhard Lisson; Marc Fabian Mezger; Daniel Wolf; Stefan Andreas Schmidt; Wolfgang M Thaiss; Eugen Tausch; Ambros J Beer; Stephan Stilgenbauer; Meinrad Beer; Michael Goetz Journal: Cancers (Basel) Date: 2022-04-15 Impact factor: 6.575